Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer

Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Hormonal Therapy in Older and/or Frail Women: A Survey of Oncologists and Geriatricians

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00478283

Enrollment

300

Registered

2007-05-24

Start date

2006-12-31

Completion date

2007-10-31

Last updated

2010-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer

Brief summary

RATIONALE: A patient's age, health, and ability to perform daily activities may affect which treatment options are offered by doctors to older and/or frail women with breast cancer. PURPOSE: This clinical trial is studying the views and attitudes of oncologists and geriatricians on the use of chemotherapy and hormone therapy in treating older and/or frail women with breast cancer.

Detailed description

OBJECTIVES: * Evaluate the attitudes and perspectives of 150 oncologists and 150 geriatricians or primary care providers regarding the adjuvant treatment of older women with breast cancer of varying ages, health, and functional status. * Determine whether homogeneity exists in treatment recommendations. * Determine the relative impact of chronological age, baseline health, and functional status on treatment recommendations. OUTLINE: Participants complete a 25-minute online survey regarding their treatment recommendations for older women with breast cancer of varying ages, health, and functional status. PROJECTED ACCRUAL: A total of 300 participants will be accrued for this study.

Interventions

OTHERsurvey administration

Study design

Primary purpose

HEALTH_SERVICES_RESEARCH

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

DISEASE CHARACTERISTICS: * Participants must meet 1 of the following criteria: * Oncologist: * Must have been in practice ≥ 2 years * Must have ≥ 25 postmenopausal breast cancer patients on adjuvant hormonal therapy * Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA * Geriatrician: * Must have been in practice ≥ 2 years * Must be a general practitioner, family practitioner, internal medicine specialist, or geriatrician and received a certificate of added qualification in geriatric medicine and/or treating at least 5 postmenopausal patients who have a history of breast cancer or are currently undergoing treatment for breast cancer * Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Design outcomes

Primary

Measure	Time frame
Attitudes and perspectives of health professionals	—
Homogeneity of treatment recommendations	—
Relative impact of chronological age, baseline health, and functional status on treatment recommendations	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026